Quantum-Si, biotech stock near pivot

Quantum-Si QSI, develops access to the proteome with single-molecule analysis and democratizing to researchers & clinicians

Also, "is the world’s first-to-market provider of protein sequencing instruments with core technology based on proprietary time-domain sequencing that enables resolution of amino acids during experiments".- Ark Invest

The stock is near finalizing its bottoming process with a pivot buy at $2.50

The Biotech ETF XBI already broke out so QSI is no leader, but still is a good set up.
biotechChart PatternsTechnical IndicatorsQSITrend AnalysisXBI

Also on:

Disclaimer